Clinical Trial Update: A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, efficacy, and pharmacokinetics of ABCD in patients with invasive mold disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Mold Disease

Drugs mentioned

• ABCD (ABCD)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Invasive Mold Disease | Phase 3 | Status: COMPLETED